TipRanks on MSN
MicroPort NeuroTech steps up competition in brain vascular devices with new embolic agent trial
MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...
There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.
TipRanks on MSN
Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors
Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
A new study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité -- Universitätsmedizin Berlin challenges a widely held ...
Baystreet.ca News Commentary – The global oncology market is projected to reach US$668.26 billion by 2034[1], as investors ...
Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...
This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...
Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback